Board-Composition (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE provides guidance on scenarios that cannot be considered for waiver or reduction of fines under SEBI LODR regulations. | |||||||||||||||
BSE provides guidance on scenarios that cannot be considered for waiver or reduction of fines under SEBI LODR regulations.
| |||||||||||||||
BSE circular outlining scenarios where waiver applications for regulatory fines cannot be considered, focusing on compliance requirements … | |||||||||||||||
BSE circular outlining scenarios where waiver applications for regulatory fines cannot be considered, focusing on compliance requirements for listed entities.
| |||||||||||||||
NSE cancels the planned suspension of trading in Shree Ram Proteins Limited securities effective August 28, 2025. | |||||||||||||||
NSE cancels the planned suspension of trading in Shree Ram Proteins Limited securities effective August 28, 2025.
| |||||||||||||||
NSE announces discontinuation of weekly trading for Gangotri Textiles Limited effective September 09, 2025, after completing mandated six … | |||||||||||||||
NSE announces discontinuation of weekly trading for Gangotri Textiles Limited effective September 09, 2025, after completing mandated six months trading period.
| |||||||||||||||
NSE suspends trading in Shree Ram Proteins Limited due to non-compliance with board composition requirements for two consecutive quarters. | |||||||||||||||
NSE suspends trading in Shree Ram Proteins Limited due to non-compliance with board composition requirements for two consecutive quarters.
| |||||||||||||||